The MRC OX-44 molecule, which is expressed on all peripheral leukocytes, identifies the subset of thymocytes capable of proliferating in response to alloantigens and lectins (Paterson, D. J., J. R. Green, W. A. Jefferies, M. Puklavec, and A. F. Williams. 1987 .J. Exp. Med. 165:1). When we isolated monoclonal antibodies (mAbs) on the basis of their ability to activate the phosphatidylinositol signaling pathway in RNK-16 cells (a rat leukemia line with natural killer activity), three of the resulting mAbs recognized the OX-44 molecule. Addition of these mAbs to R.NK-16 elicits protein tyrosine phosphorylation, generates inositol phosphates, and increases the concentration of cytoplasmic free calcium. These responses require the addition of intact mAb and are not observed with F(ab')2 fragments. One of these mAbs (7D2) is mitogenic for freshly isolated rat splenic T cells and synergizes with a mAb to the T cell antigen receptor in this activation. A 50-60-kD glycoprotein coprecipitates with the OXo44 molecule from RNK-16 cells and rat splenic T cells. Peptide mapping and reprecipitation studies indicate that the coprecipitating molecule is CD2. Thus, the OX-44 molecule can couple to multiple signaling pathways and associates with CD2 on both RNK-16 and rat T cells.
T
he MRC OX-44 molecule is expressed on all peripheral T cells but only 10% of thymocytes (1) . Among thymocytes, only those that express the OX-44 molecule proliferate in response to alloantigens or mitogenic lectins (1, 2) . The OX-44 molecule, therefore, is a phenotypic marker for functionally mature thymocytes and may have a role in regulating the responses of thymocytes and peripheral T cells to a variety of mitogenic stimuli. The structure of the OX-44 molecule and its human homologue, CD53, supports this possibility (3) (4) (5) (6) . The deduced amino acid sequences indicate that the OX-44 molecule and CD53 are members of a newly recognized family of molecules whose distinctive topology is characterized by the presence of four transmembrane spanning domains (3) (4) (5) (6) . The putative transmembrane and cytoplasmic domains of the OX-44 molecule and CD53 are highly conserved (92% amino acid identity) suggesting that these regions are critical for the function of these molecules (5, 6) . These features led Bellacosa et al. (5) to suggest that the OX-44 molecule may have a role in signal transduction. Herein, we provide evidence in support of that hypothesis.
In an effort to identify cell surface molecules capable of stimulating the phosphatidylinositol (PI) 1 signaling pathway in R.NK-16 cells (a rat leukemia line with NK cell activity), we screened for mAbs that stimulate the generation of inositol phosphates (ImPs) in RNK-16 cells. This procedure led to the isolation of mAbs directed against only three cell surface structures: CD2, gp42, and, as described here, the OX-44 molecule. Perturbation of the OX-44 molecule not only stimulates a substantial InsP response in RNK-16 cells, but also leads to the appearance of tyrosine-phosphorylated proteins. These responses require the addition of intact mAbs and are not elicited by F(ab')2 fragments. One of the mAbs recognizing the OX-44 molecule (7D2) is mitogenic for freshly isolated splenic T cells, and it augments TCR-mediated proliferation. When RNK-16 cells or freshly isolated rat T cells are solubilized in a buffer containing 3-[(3-cholamidopropyl)-dimethyl ammonio]-l-propane sulfonate (CHAPS), a 50-60-kD glycoprotein coimmunoprecipitates with the OX-44 molecule. Peptide mapping and reimmunoprecipitation studies establish that the copredpitating molecule is CD2. Thus, the OX-44 molecule can couple to signaling pathways and appears to be noncovalently associated with CD2. These properties suggest that the OX-44 molecule may play an important role in the activation of T cells and NK ceils.
Materials and Methods
Cells and Cell Culture. RNK-16 cells were adapted for in vitro growth and passaged as described (7) . To obtain splenic T cells from Fisher 344 rats (Simonsen Labs, Gilroy, CA), we passed spleens through a no. 40 mesh (Small Parts Inc., Miami, FL). The resulting cell suspension was then washed three times in RPMI supplemented with 10% FCS and resuspended in 5 ml of medium. The cell suspension was centrifuged through 5 ml of FicoU-Hypaque at 500 g for 45 min. Mononuclear cells were harvested from the interface and incubated in a nylon wool column at 37~ for 30 min. Ceils eluted from the column were collected and contained •90% T cells (by flow cytometric analysis after staining with mAb R73).
Antibodies. 
Measurement of InsPs and IntraceUular Free Calcium (Ca2+],).
InsPs were resolved and quantified as we have described (7) , by labeling cells with [3H]inositol (20/xCi/ml) for 3 h before stimulation by mAb. At intervals after stimulation, aliquots of cells (5 x 106) were rapidly pelleted and then lysed in ice-cold 10% TCA. After removal of insoluble material, the supernatant was extensively extracted with diethyl ether. Labeled InsPs were resolved by sequential elution using anion exchange chromatography with Dowex-lX8 (100-200 mesh) in formate form, as described (7 Cytotoxicity and Proliferation Assays. Cytotoxicity assays were performed as described (7) . For proliferation assays, 2 x 10 s nylon wool-nonadherent spleen cells were cultured in 200/xl of complete medium in 96-well microtiter plates for 48 h as described (10) . mAbs were added to a final concentration of 10/zg/ml. 6 h before harvesting, each well was pulsed with 1 #Ci of [3H]thymidine. Cells were harvested and [3H]thymidine incorporation was detected as described (10) .
Su~Cace Labeling, lmmunoprecipitation, and SDS-PAGE. 4 x 107
ILNK-16 cells were surface labeled with 1 mCi 12sI by the glucose oxidase method and were lysed on ice in buffers containing 20 mM TILLS (pH 7.5), 150 mM NaC1, 1 mM PMSF, 20 mM iodoacetamide, and either 10 mM CHAPS or 1% NP-40. Postnuclear supernatants were precleared with preformed complexes of Pansorbin (Calbiochem-Behring Corp., La Jolla, CA) and rabbit anti-mouse IgG antiserum before immunoprecipitation with specific mAb adsorbed to Pansorbin. Immune complexes were then washed three times in lysis buffer containing either 2 mM CHAPS or 0.2% NP-40, and the antigens were eluted with 50/~1 of Endo-F sample buffer (0.1% SDS, 50 mM EDTA, 1% 2-ME, and 0.1 M phosphate buffer [pH 6.1]). 0.2 U Endo-F (Calbiochem-Behring Corp.) was added to appropriate aliquots and incubated overnight at 37~ Alternatively, immunoprecipitates were treated with N-glycanase (Genzyrne, Boston, MA) according to manufacturer's instructions. An equal volume of twofold concentrated Laemmli sample buffer was added, and the samples were analyzed under reducing conditions by SDS-PAGE, followed by autoradiography. For reprecipitation studies, RNK-16 ceils were first surface labeled and lysed in a buffer containing CHAPS. The immune complex was then washed once in 2 mM CHAPS and then resuspended in 150/zl lysis buffer containing 1% NP-40 and allowed to stand at room temperature for 30 min. The immune complex was then pelleted and the supernatant harvested. The immune complex was washed once more and then eluted in Laemmli sample buffer. The NP-40-containing supernatant was subjected to reimmunopredpitation by specific mAbs. Samples were analyzed under reducing conditions on 10% polyacrylamide gel by SDS-PAGE and autoradiography.
Peptide Mapping. Immunoprecipitations from ~2sI surfacelabeled RNK-16 cells using mAb 2D1 (which recognizes the OX44 molecule), OX-34 (which recognizes rat CD2), and OX-18 (which recognizes rat MHC class I molecules) were carried out as described above. Gel slices from Endo F-treated samples containing class I molecules, directly immunoprecipitated CD2, or the 42-kD protein that coprecipitated with the OX-44 molecule were rehydrated and treated with V8 protease (Calbiochem-Behring Corp.) according to the technique of Cleveland et al. (11) . Samples were analyzed on 15% polyacrylamide gels by SDS-PAGE and autoradiography.
Results

Isolation of mAbs that Stimulate PI Turnover in RNK-16
Cells. To identify potential signal-transducing molecules on rat lymphocytes, we generated hybridomas from the spleens of BALB/c mice that had been immunized with KNK-16 cells.
The resulting hybridoma supernatants were tested initially for binding to KNK-16. 93 supernatants containing binding mAbs were screened for ImPs production using a goat anti-mouse Ig antiserum as a crosslinking agent. Subcloning of the hybridomas that tested positive led to the isolation of 11 mAbs with agonist properties. An additional 76 supernatants were screened in the absence of a second-step antiserum; this procedure led to the isolation of only one mAb (designated 7D2). Of the 12 mAbs selected, three recognized CD2, and six recognized gp42, a glycosylphosphatidylinositol (GPI)-anchored protein expressed by activated rat NK cells. In our initial studies of the remaining three mAbs (7D2, 2D1, and 6E2), we found that incubation of RNK-16 cells with any one of these prevented the subsequent binding of the others, suggesting that the three mAbs bind near the same epitope. To characterize the molecule recognized by these mAbs, KNK-16 cells were labeled with nsI and then solubilized with NP-40. From the resulting lysate, 7D2 immunoprecipitated a broad band with a mean molecular mass of 35 kD under both reducing ( Fig. 1 lane A) and nonreducing conditions (data not shown). Treatment of the immunoprecipitate with N-glycanase resulted in the appearance of a single, sharp band of 23 kD ( Fig. 1 B ). An identical result was obtained with 2D1 and with 6E2. Thus, these mAbs recognize a single chain glycoprotein of 35 kD that has a protein core of 23 kD.
As demonstrated using 7D2, the addition of these mAbs to [3H]inositol-labeled RNK-16 cells stimulates a substantial (four-to fivefold) and sustained (>10 min) increase in inositol trisphosphate (InsP3) and in its metabolites, inositol bisphosphate (InsP2), and inositol phosphate (InsP1) (Fig. 2  A) , confirming that these mAbs activate the PI pathway in KNK-16 cells. Consistent with the link between PI turnover and Ca 2 + fluxes, 7D2 elicits a sustained increase in the concentration of [Ca2+]i in Indo-l-loaded RNK-16 cells (Fig.  2 B) . This signaling response required the Fc region of mAb. F(ab')2 fragments of mAb 7D2 failed to elicit an increase in [Ca2+]i, suggesting that interactions with Fc receptors are required for the agonist properties of the mAb (data not shown).
mAb 7192 Stimulates Protein Tyrosine Phosphorflation. One mechanism by which cell surface receptors couple to the PI pathway is through the activation of protein tyrosine kinases. Accordingly, we determined whether the addition of 7D2 to RNK-16 leads to the appearance of tyrosine-phosphorylated proteins. We compared the response to 7D2 with the response to pairs of mAbs against CD2. CD2 is known to stimulate PI turnover in KNK-16 and, in human T cells, induces protein tyrosine phosphorylations (7, 12) . As shown in Fig. 3 , the tyrosine phosphorylation of several proteins is induced by 7D2, and at least two of these are also induced by stimulating CD2. In contrast, the addition of an isotypematched mAb (OX-18) to rat MHC class I molecules does not lead to protein tyrosine phosphorylation. The combination of ionomycin and phorbol myristate acetate induces the tyrosine phosphorylation of only the 42-kD protein, suggesting that the majority of 7D2-and CD2-mediated tyrosine phosphorylations are not a consequence of PI turnover. Consistent with their inability to stimulate calcium signaling, F(ab')2 fragments of mAb 7D2 failed to stimulate protein tyrosine phosphorylations (data not shown).
mAb 7D2 Inhibits Killing by RNK-16 Cells. RNK-16 cells spontaneously lyse the NK-sensitive target, YAC-1 (7). As shown in Fig. 4 , the killing of YAC-1 targets is inhibited by 7D2 but not by isotype-matched control mAbs to MHC class I molecules or to CD8 (both of which are expressed on RNK-16). The inhibitory effect of 7D2 is comparable with that of the CD2 mAb, OX-34, which has been shown to inhibit killing by KNK-16 (7). (Tables 1 and 2 ), whereas other mAbs to OX-44 molecule (OX-44, 2D1, and 6E2) did not (data not shown). The proliferative response of T cells to 7D2 was substantially less than that elicited by Con A but was somewhat greater than the response to optimal concentrations of mAb K73, which recognizes all TCK-cff/~ structures in the rat (Table 1 ) (13). The level of the proliferative responses to R73 in these experiments agreed with previously reported studies using this mAb (13) . Both 7D2 and K73 are BALB/c IgG1 mAbs, indicating that the greater response to 7D2 is not a reflection of its isotype. Moreover, there were no kinetic differences between the responses to the two mAbs; peak proliferation to each mAb occurred at 48 h, and the response to 7D2 was greater than the response to anti-TCK at 24 and 72 h as well (not shown). In contrast to the results obtained with (14) . T cell proliferation in response to the combination of 7D2 and anti-TCK (R73) was greater than the sum of the individual responses (Table 2 ). There was no enhancing effect when either mAb was used in combination with OX-18 (not shown). Only a modest augmentation of the K73 response was elicited by the CD2 mAbs OX-55 (Table 1) (Fig. 6, lanes  1 and 3) . This coprecipitation was observed with three separate mAbs to the OX-44 molecule (2D1, 7D2, and OX-44) but not with a mAb to MHC class I molecules (OX-18; not shown). After Endo F treatment, the coprecipitating molecule migrated as a sharp band of 42 kD (Fig. 6, lane 2) . A band of this mass was usually observed after Endo F treatment of immunoprecipitates from NP-40 lysates (Fig. 6, lane  4) , but the intensity of the 42-kD band was variable and substantially less than that from the CHAPS lysate (compare Figs. 1 and 6 ). It appears, therefore, that small amounts of the 50-60-kD molecule are present in immunoprecipitates from NP-40 lysates and that deglycosylation substantially increases detection of this molecule.
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In both glycosylated and deglycosylated forms, the coprecipitating molecule migrated on SDS-PAGE at the same mass as CD2 obtained by immunoprecipitation from RNK-16 lysates (not shown, but see below, Figs. 8 and 9). To determine whether the coprecipitating molecule was CD2, we excised the 42-kD band from the Endo F-treated immunoprecipitates of the OX-44 molecule and performed peptide maps. After digestion with either staphylococcal V8 protease (Fig. 7) or chymotrypsin (not shown), the peptide maps of the coprecipitating molecule were identical to those of Endo F-treated CD2 (Fig. 7) . In contrast, a different map was generated by digestion of Endo F-treated MHC class I molecules, which migrated with a similar apparent mass (43 kD) on SDS-PAGE (Fig. 7) .
To further confirm the identity of the 50-60-kD molecule as CD2, we took advantage of the differential abilities of CHAPS and NP-40 to permit coprecipitation. 125I-surfacelabeled RNK-16 cells were solubilized in lysis buffer containing CHAPS, which allows coprecipitation, and immunoprecipitations were performed using 2D1, a mAb to the OX-44 molecule. When the immunoprecipitates were washed in CHAPScontaining buffers, the 50-60-kD glycoprotein coprecipitated 3 and 4) . Immunoprecipitates were either untreated (lanes 1 and 3) or digested with Endo F (lanes 2 and 4) before analysis under reducing conditions by SDS-PAGE using an 11% polyacrylamide gel followed by autoradiography. Figure 7 . The Peptide map of CD2 is identical to that of the protein that coprecipitates with the OX-44 molecule. Gel slices containing Endo F-treated CD2 (lanes 2 and 4), Endo F-treated coprecipitating molecule (lanes 3 and 5), and Endo F-treated MHC class I molecule (lane I) were partially digested with 1/~g (lanes 2 and 3), 0.2 #g (lane 1), or 0.05/zg (lanes 4 and 5) Staphylococcal V8 protease and analyzed by SDS-PAGE and autoradiography. 12Sl-labeled RNK-16 were solubilized in buffer conraining 10 mM CHAPS, and immunoprecipitations were performed using mAbs OX-34 (anti-CD2), 2D1 (which recognizes the OX-44 molecule), and OX-18 (anti-MHC class I). The immunoprecipitates were digested with Endo F, resolved by SDS-PAGE, and visualized by autoradiography. The regions containing CD2, the 42-kD protein that coprecipitates with the OX-44 molecule, and MHC class I molecules were excised from the dried gels. These gel slices were rehydrated and treated with V8 protease according to the technique of Cleveland et al. (11) . Samples were analyzed by SDS-PAGE (using 15% polyacrylamide gels) followed by autoradiography. Figure 8 . CD2 coprecipitates with the OX-44 molecule from CHAPS lysates of RNK-16. ~I-labeled RNK-16 cells were sohbilized in lysis buffer containing 10 mM CHAPS, divided into equal aliquots, and then subjected to immunoprecipitation using 2D1, a mAb to the OX-44 molecule. (Lane I) The immunoprecipitate was washed in 2 mM CHAPS and then eluted with Laemmli sample buffer. Alternatively, the immunoprecipitate was washed once in 2 mM CHAPS and then resuspended in buffer containing 1% NP-40. After a 30-min incubation, the immunoprecipitate was pelleted and eluted in Laemmli sample buffer (lane 2). The NP-40 incubation buffer was then divided and subjected to immunoprecipitation using mAbs to CD2 (OX-34; lane 3) or to CD8 (OX-8; lane 5). (Lane 4) CD2 was immunoprecipitated directly by mAb OX-34 from solubilized 12H-labeled RNK-16. Samples were analyzed under reducing conditions on a 10% polyacrylamide gel, followed by autoradiography of the dried gel.
with the OX-44 molecule (Fig. 8, lane 1) . However, if the 2D1 immunopredpitates were incubated in a buffer containing 1% NP-40 before SDS-PAGE, the 50-60-kD band dissociated from the immune complex (Fig. 8, lane 2) . The dissociated 50-60-kD molecule could then be immunoprecipitated from the NP-40 incubation buffer by mAb to CD2 (Fig. 8, lane 3) but not to CD8 (Fig. 8, lane 5) , and it comigrated with CD2 that was immunoprecipitated directly from the RNK-16 lysate (Fig. 8, lane 4) . In contrast to these results, CD2 could not be detected in immunoprecipitates of MHC class I molecules (not shown).
The OXo44 molecule obtained by immunoprecipitation from splenic T cells migrated at a higher apparent mass (35-45 kD) than the OX-44 molecule immunoprecipitated from RNK-16 cells. This difference in size was due to differential glycosylation; the deglycosylated molecules from RNK-16 and from T cells have the same apparent mass on SDS-PAGE. To determine whether CD2 coprecipitated with the OX-44 molecule from lysates of T lymphocytes, we surface labeled freshly isolated rat splenic T cells with 125I and solubilized these cells in a CHAPS-containing buffer. From these lysates 2D1 immunoprecipitated a diffuse band of 35-50 kD (Fig.  9 a, lane 1) . Digestion with Endo F resulted in the appearance of the 23-kD deglycosylated OX-44 molecule. As in RNK-16 cells, it was associated with a 42-kD molecule that had the same electrophoretic mobility as deglycosylated CD2 (Fig. 9 a, lanes 3 and 4) . Peptide mapping studies confirmed that this coprecipitating 42-kD molecule was CD2 (Fig. 9  b) . A third band of 31 kD also appeared in the Endo F digests of the 2D1 immunoprecipitates (Fig. 9 a, lane 3) , but this was not a consistent finding. The identity of this band is unknown.
Discussion
Our studies establish that the OX-44 molecule, when stimulated by mAbs, can transduce transmembrane signals. We also observe that CD2 coprecipitates with the OX-44 molecule, an indication that the two molecules are probably physically associated on the cell surface. Consistent with this possibility, we find that perturbation of the OX-44 molecule has effects on signal transduction and cellular responses that are similar to those elicited by stimulating CD2. In KNK-16 cells, each of the molecules can stimulate PI turnover, induce protein tyrosine phosphorylations, and inhibit target cell lysis. When stimulated by appropriate mAbs, either molecule can trigger the proliferation of T lymphocytes. We also find that stimulating the OX-44 molecule augments TCR-mediated proliferation. We did not observe a comparable enhancing effect of mAbs to rat CD2, but synergy between mAbs to CD2 and TCK has been reported in human systems (15) . Taken together, these findings suggest that the OX-44 molecule may participate in CD2-mediated responses.
Our studies also indicate that the agonist properties of mAb 7132 on RNK-16 cells depend upon the Fc region of the mAb and cannot be duplicated with F(ab')2 fragments. This result suggests that signaling by the OX-44 molecule requires Fc receptor ligation, either as a costimulus or as a means of crosslinking the mAb. Recently, Spruyt et al. (16) have observed that Ca 2 + signaling by CD2 mAbs in RNK-16 (but not T cells) also requires Fc receptor ligation.
The ability of mAb 7D2 to activate T cells in the absence of exogenous comitogens is shared by mAbs to a limited number of molecules, most notably (but not exclusively) the TCR/CD3 complex and CD2 (14, 15) . It should also be pointed out that our screen of nearly 200 hybridoma supernatants containing mAbs binding to RNK-16 led to the isolation of mAbs to only three cell surface structures: the OX-44 molecule, CD2, and gp42. The isolation of mAb to CD2 was anticipated, given the well-recognized ability of CD2 to signal in T cells and NK cells and our earlier finding that perturbation of CD2 by mAb generates a substantial InsP response in RNK-16 cells (7, 14, 17, 18) . gp42 is a GPIanchored protein that is selectively expressed by rat NK cells after activation by II-2 (19, 20) . The ability to stimulate PI turnover appears to be a general feature of GPI-anchored proteins on lymphocytes (21) .
The gene encoding the OX-44 molecule has recently been cloned, and the predicted amino acid sequence indicates that it is the rat homologne of human CD53 (3-6). These molecules are members of a newly recognized family of glycoproteins that includes CD37, CD9, TAPA-1, ME491, CO-029, and Sm23 (3) (4) (5) (6) (22) (23) (24) (25) (26) (27) . Members of this family lack a conventional leader sequence and are predicted to have four transmembrane domains with both their NH2 and COOH termini located intracdlularly (3) (4) (5) (6) (22) (23) (24) (25) (26) (27) . When sequences for a particular family member are compared from different species, the putative cytoplasmic and transmembrane domains are highly conserved. For example, the NH2-terminal hydrophilic region of the OX-44 molecule is identical to that of human CD53 (5, 6) . Similarly, the cytoplasmic domains of human and rat CD37 are identical at 27 of 28 residues, an indication that these regions of CD37 are critical for its function (3, 4) .
Although little is known concerning the physiological functions of this family of glycoproteins, recent studies of CD9, ME491, and TAPA-1 suggest that these molecules have roles in regulating signaling processes (25, (28) (29) (30) . The addition ofCD9 mAbs to platelets stimulates PI turnover, an increase in [Ca2+]i, granule secretion, and aggregation (28) . Perturbation of CD9 also induces a physical association between CD9 and the platelet glycoprotein IIb-IIIa complex (the fibrinogen receptor), an event that could contribute to the conformational change necessary for exposure of the binding site for fibrinogen (29) . ME491 was initially recognized on human melanoma cells (24) . Kitani et al. (25) recently isolated a mAb (AD1) to the probable rat homologue of ME491 by screening mAbs for the ability to inhibit IgE-mediated release of histamine from a rat basophilic leukemia line. Although rat ME491 is not a known component of the high affinity IgE receptor (FceRI), selected mAb to the FceRI blocked the binding of AD1, suggesting that rat ME491 is in close physical proximity to the FceRI (25) . The ability of AD1 to inhibit IgE-mediated histamine release (but not the binding of IgE) suggests that rat ME491 may alter signaling by the FceRI (25) . mAbs to TAPA-1 were derived by screening for mAbs that inhibited the in vitro growth of lymphomas (23) . These mAbs induce cell aggregation that is temperature sensitive and, therefore, may involve a TAPA-1-mediated signaling event (30) . In certain cell lines, TAPA-1 has been shown to associate with a complex of cell surface molecules that includes Leu-13 (30) . Thus, three molecules that are related to the OX-44 molecule have the capacity to modulate cellular responses and appear to physically associate with cell surface receptors.
Further studies are needed to determine whether the OX-44 molecule plays a role in the physiological activation of T cells and NK cells and to assess the functional importance of its interaction with CD2. CD2 has a large (116 amino acids) cytoplasmic domain, and this domain is required for CD2-mediated signaling (31, 32) . CD2 does not signal when expressed in fibroblasts, suggesting that CD2 interacts with lineage-restricted molecules in order to transduce activation signals (31) . It is highly probable that CD2 functionally interacts with several distinct cell surface structures. CD2-mediated signaling in human T cell lines is augmented by expression of the TCR/CD3 complex (33) (34) (35) . A physical association between CD2 and this complex has been reported by some, but not other, investigators (36, 37) . CD2 also appears to interact with the tyrosine phosphatase, CD45, which can be chemically crosslinked to CD2 on human T cells and which is required for signal transduction through CD2 and the TCR/CD3 complex (38) (39) (40) (41) . Like CD45, the OX-44 molecule is expressed by all mature leukocytes, suggesting that it is functional in cells that do not express CD2. It will be of interest to explore the signaling ability of the OX-44 molecule in these cells and to determine whether it can associate with ligand-binding molecules other than CD2.
